Home
Scholarly Works
Stereotactic Radiotherapy for Oligoprogression in...
Journal article

Stereotactic Radiotherapy for Oligoprogression in Metastatic Kidney Cancer Patients Receiving Tyrosine Kinase Inhibitor Therapy: A Prospective Phase II Multi-Centre Study

Authors

Cheung P; Patel SI; North S; Sahgal A; Chu W; Soliman H; Ahmad B; Winquist E; Niazi TM; Pantenaude F

Journal

International Journal of Radiation Oncology • Biology • Physics, Vol. 108, No. 3, pp. s27–s28

Publisher

Elsevier

Publication Date

November 1, 2020

DOI

10.1016/j.ijrobp.2020.07.2121

ISSN

0360-3016

Contact the Experts team